Lynch Thomas G 4
4 · GW PHARMACEUTICALS PLC · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Lynch Thomas G
Director
Transactions
- Award
Stock Options
2019-03-01+16,548→ 16,548 totalExercise: $14.33From: 2022-03-01Exp: 2029-03-01→ Ordinary Shares (16,548 underlying) - Award
Stock Options
2019-03-01+3,144→ 3,144 totalExercise: $0.00From: 2021-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying) - Award
Stock Options
2019-03-01+3,144→ 3,144 totalExercise: $0.00From: 2020-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying) - Award
Stock Options
2019-03-01+3,144→ 3,144 totalExercise: $0.00From: 2022-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying)
Footnotes (4)
- [F1]Granted pursuant to the Issuer's Long-Term Incentive Plan.
- [F2]The reported options are options to purchase American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- [F3]The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
- [F4]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.